Emerson Exchange 365

Blogs

Jim Cahill
- 5 Jun 2017
Enabling Right-the-First-Time Manufacturing

Quality and compliance are indispensable in pharmaceutical and biopharmaceutical manufacturing processes. In a Pharmaceutical Manufacturing magazine article, Crazy About Quality and Compliance? , Emerson’s Michalle Adkins shares how organizational engagement, technologies and work practices must come together for safe, efficient and profitable manufacturing. Michalle opens sharing her experiences in pharmaceutical...
Jim Cahill
- 4 May 2017
Improving Raw Material Management Productivity

For manufacturers in highly-regulated industries, such as pharmaceutical and biopharmaceutical manufacturing, it is critical to keep track of raw materials as part of the production records. To minimize or avoid waste, it’s also important to use the first-to-expire raw materials from inventory. I caught up with Emerson’s Lynn Richard about his experiences to help a manufacturer solve this challenge and...
Jim Cahill
- 24 Apr 2017
Challenge of Designing PCS-Driven MES Architectures for a Greenfield Facility

Author: Jonathan Lustri I have previously written about a design strategy where the process control system (PCS) is the primary system driving all procedural batch activity within a pharmaceutical process. In this architecture, the PCS ISA-88 procedural model must execute the both automated procedures and call the manufacturing execution system (MES) workflows to be executed when they are needed by the process. The...
Jim Cahill
- 17 Apr 2017
Efficient Technology Transfer across Life Sciences Product Development Lifecycle

Pharmaceutical and biotech manufacturers are challenged with bringing new medicines and drug compounds efficiently through the development process to provide returns on these investments before exclusivity expires. In a Pharmaceutical Manufacturing article, Tech Transfer: Let’s Take It from the Top , Emerson’s Bob Lenich highlights the importance of a top down approach to technology transfer across the...
Jim Cahill
- 5 Apr 2017
Big Data and Process Analytics for Continued Process Verification

A biological drug is defined as a: …substance that is made from a living organism or its products and is used in the prevention, diagnosis, or treatment of cancer and other diseases. Biological drugs include antibodies, interleukins, and vaccines. The market for biological drugs continues to rapidly grow. In fact, in China alone, there were 201 Biological New Drug Applications (NDAs) in 2016, a 32% increase...
Jim Cahill
- 24 Mar 2017
Automating Bioprocess Single-Use Systems

For those not in the pharmaceutical and biotech manufacturing industries, if you ever visit one of these facilities you’ll be struck by the clean, shiny stainless steel vessels and piping. Given the importance of hygiene in the production of medicines, most processes include clean-in-place (CIP) and sterilize-in-place operations (SIP). The capital costs and ongoing time requirements for this stainless-steel equipment...
Jim Cahill
- 14 Mar 2017
Capital Project Efficiency-Operational Flexibility-Product Lifecycle Efficiency at Interphex

Author: Michalle Adkins At the March 21-23 Interphex 2017 , Emerson exhibitor staff will be discussing three main themes: delivering capital projects on time with lower risk; comprehensive automation solutions for flexible, single-use facilities; and improving efficiency across the product lifecycle. Life Sciences companies are expanding globally in order to provide life-saving or life-enhancing solutions to more...
Jim Cahill
- 26 Jan 2017
Best Practices Specifying MES Workflows for Life Sciences Projects

Author: Jonathan Lustri Manufacturing Execution System (MES) Life Sciences projects can be costly and be a challenge to keep in control. The biggest contributor to these challenges are the defining and design of manufacturing workflows. A Workflow is an MES procedural object used to replace the paper batch record. And for greenfield projects in particular, this can be a challenge. In order to define best practices...
Jim Cahill
- 10 Jan 2017
Measurement Repeatability in CIP and SIP Operations

One only has to do a Google image search on pharmaceutical equipment to see the clean, sanitary conditions required for pharmaceutical and biopharmaceutical processing. The measurement instrumentation must be able to handle the tough conditions when cleaning and sanitization operations are performed. In a Pharmaceutical Manufacturing article, Ensuring Batch-to-Batch Repeatability in Sanitary Processes , Emerson’s...
Jim Cahill
- 10 Nov 2016
Pharmaceutical and Biotech Manufacturing Data Integrity

The integrity of the data behind the production of pharmaceutical products is paramount. In recent years, the U.S. Food & Drug Administration (FDA) has increasingly observed data integrity related Current Good Manufacturing Practices (CGMP) violations during CGMP inspections. At the recent Emerson Exchange conference, Emerson’s Michalle Adkins co-moderated the Life Sciences Industry Forum session with experts...

Emerson Exchange 365

zjinemerson

zerocool

zahe

Youssef.El-Baht...

yogii1

YogBhagwat

Xu Ning

Xiaoyu Zhang

WS214

WRoss

wiwin84

WillGoetz

will.luong

Will Irwin

widanta

Wayne Brinkman

wasimmulani

wale

VKEMR

vivekbabar

Victor OBrien

Vicky Uy 黄美琪

vallancel

Vadim

uttam.gherkar

usman.younis

Usman.Ali

Umar Qadeer

umamaheswaran

Ukhalid